Global Health Ltd (Medanta) (NSE: MEDANTA, BSE: 543654) is a Gurugram, Haryana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹33,340 Cr, it ranks #261 by market cap among the 6,137 Indian listed companies on FinBizNet, and #6 of 42 in Hospitals and Healthcare Centers. At ₹1,185.00 (as of 25 Oct 2026), the share price is 23.3% below its 52-week high of ₹1,544.00 and 24.0% above its 52-week low of ₹956.00. The share price is down 15.1% over one year and down 13.6% over three months.
| Current Price | ₹1,185.00 |
|---|---|
| Market Cap | ₹33,340 Cr |
| NSE Symbol | MEDANTA |
| BSE Code | 543654 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 60 |
| Return on Equity | 15.03% |
| Return on Assets | 8.22% |
| 52-Week Range | ₹956.00 – ₹1,544.00 |
| 1-Year Price Change | -15.1% |
| 3-Month Price Change | -13.6% |
| Beta (1Y) | 0.28 |
| Dividend Yield | 0.04% |
| Headquarters | Gurugram, Haryana |
| Website | www.medanta.org |
| Revenue | ₹1,304 Cr |
|---|---|
| Net Profit | ₹157 Cr |
| Net Margin | 12.1% |
| EPS (Basic) | ₹5.91 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and ot
1. The Healthcare Services-This segment offers healthcare services. 2. 0-0 3. 0-0 4. 0-0
1. The Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Rainbow Children'S Medicare Limited | ₹12,685 Cr | 45.1 | 17.94% | ₹470 Cr | -11.6% |
Listed by market capitalisation. Ratios are shown for context only.
Global Health Ltd (Medanta) is trading at ₹1,185.00, with a market capitalisation of ₹33,340 Cr.
Global Health Ltd (Medanta) operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Global Health Ltd (Medanta) has a P/E of 60 and a return on equity of 15.03%.
Global Health Ltd (Medanta) is listed on the NSE under the symbol MEDANTA and on the BSE under the scrip code 543654.
Global Health Ltd (Medanta)'s share price is down 15.1% over one year and down 13.6% over three months. Its 52-week range is ₹956.00 to ₹1,544.00.
In Q1 FY27, Global Health Ltd (Medanta) reported revenue of ₹1,304 Cr and net profit of ₹157 Cr, with basic EPS of ₹5.91 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.